Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trialBruno François, Alain Lepape, Frank E. J. Coenjaerts et al.|The Lancet Infectious Diseases|2021Cited by 88
Community-acquired Staphylococcus aureus bacteriuria: a warning microbiological marker for infective endocarditis?Thomas Lafon, Philippe Vignon, Ana Catalina Hernandez Padilla et al.|BMC Infectious Diseases|2019Cited by 25
Immature granulocytes can help the diagnosis of pulmonary bacterial infections in patients with severe COVID-19 pneumoniaThomas Daix, Bruno François, Robin Jeannet et al.|Journal of Intensive Care|2021Cited by 13
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseasesNasreen Hassoun‐Kheir, Marlieke E.A. de Kraker, C. Henri van Werkhoven et al.|Clinical Microbiology and Infection|2022Cited by 12
Performance of the Cepheid Methicillin-Resistant Staphylococcus aureus/S. aureus Skin and Soft Tissue Infection PCR Assay on Respiratory Samples from Mechanically Ventilated Patients for S. aureus Screening during the Phase 2 Double-Blind SAATELLITE StudyAlexey Ruzin, Mark T. Esser, Olivier Barraud et al.|Journal of Clinical Microbiology|2022Cited by 11